NAFLD: The evolving landscape

被引:21
作者
George, Jacob [1 ,2 ]
Anstee, Quentin [3 ,4 ]
Ratziu, Vlad [5 ]
Sanyal, Arun [6 ]
机构
[1] Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Sydney, NSW, Australia
[2] Univ Sydney, Sydney, NSW, Australia
[3] Newcastle Univ, Inst Cellular Med, Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England
[4] Freeman Rd Hosp, Newcastle Upon Tyne Hosp NHS Trust, Liver Unit, Newcastle Upon Tyne, Tyne & Wear, England
[5] Sorbonne Univ, Hosp Pitie Salpetriere, Inst Cardiometab & Nutr, Paris, France
[6] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Richmond, VA USA
关键词
LIVER-DISEASE; FIBROSIS;
D O I
10.1016/j.jhep.2017.11.016
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:227 / 229
页数:3
相关论文
共 19 条
[1]   The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease [J].
Boyle, Marie ;
Masson, Steven ;
Anstee, Quentin M. .
JOURNAL OF HEPATOLOGY, 2018, 68 (02) :251-267
[2]   MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice [J].
Dulai, Parambir S. ;
Sirlin, Claude B. ;
Loomba, Rohit .
JOURNAL OF HEPATOLOGY, 2016, 65 (05) :1006-1016
[3]   Genetics and epigenetics of NAFLD and NASH: Clinical impact [J].
Eslam, Mohammed ;
Valenti, Luca ;
Romeo, Stefano .
JOURNAL OF HEPATOLOGY, 2018, 68 (02) :268-279
[4]   Acid sphingomyelinase-ceramide system in steatohepatitis: A novel target regulating multiple pathways [J].
Garcia-Ruiz, Carmen ;
Mato, Jose M. ;
Vance, Dennis ;
Kaplowitz, Neil ;
Fernandez-Checa, Jose C. .
JOURNAL OF HEPATOLOGY, 2015, 62 (01) :219-233
[5]   Pharmacotherapy for NASH: Current and emerging [J].
Konerman, Monica A. ;
Jones, Jacob C. ;
Harrison, Stephen A. .
JOURNAL OF HEPATOLOGY, 2018, 68 (02) :362-375
[6]   Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence? [J].
Lonardo, Amedeo ;
Nascimbeni, Fabio ;
Mantovani, Alessandro ;
Targher, Giovanni .
JOURNAL OF HEPATOLOGY, 2018, 68 (02) :335-352
[7]   Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions [J].
Loomba, Rohit .
JOURNAL OF HEPATOLOGY, 2018, 68 (02) :296-304
[8]   Lipotoxicity and the gut-liver axis in NASH pathogenesis [J].
Marra, Fabio ;
Svegliati-Baroni, Gianluca .
JOURNAL OF HEPATOLOGY, 2018, 68 (02) :280-295
[9]   NAFLD and liver transplantation: Current burden and expected challenges [J].
Pais, Raluca ;
Barritt, A. Sidney ;
Calmus, Yvon ;
Scatton, Olivier ;
Runge, Thomas ;
Lebray, Pascal ;
Poynard, Thierry ;
Ratziu, Vlad ;
Conti, Filomena .
JOURNAL OF HEPATOLOGY, 2016, 65 (06) :1245-1257
[10]   Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease [J].
Pawlak, Michal ;
Lefebvre, Philippe ;
Staels, Bart .
JOURNAL OF HEPATOLOGY, 2015, 62 (03) :720-733